The FDA has confirmed a nationwide shortage of Adderall.
Teva, the largest maker of generic Adderall in the U.S., told ABC News "the supply that we are manufacturing/distributing right now is on pace to be consistent - or greater than - our supply at this time last year by the end of this year. The demand is not."
While another supplier of the drug, Sandoz Pharmaceuticals told ABC News there is no "shortage" of Sandoz amphetamine in the market at this time and the company is meeting all current customer orders. There are many reasons for constrained supply, including tight regulation due to its classification as a schedule II drug which the DEA defines as "drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence." In addition, labor shortages, supply chain issues and an increase in the number of people who have been prescribed the drug in recent years may have an effect on supply.
If people are struggling to obtain their medication and feel they've exhausted all options, they should call their pharmacist or doctor to discuss a plan.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Raisin Bran, Honey Nut Cheerios among cereals not defined as 'healthy' under proposed FDA criteriaUnder the FDA’s newly-proposed 'healthy' definition for food packaging, salmon, nuts, and seeds would now qualify, while many breakfast cereals would not.
Read more »
FDA clears updated COVID boosters for kids as young as 5Officials hope to expand protection against an expected winter surge.
Read more »
FDA clears updated COVID boosters for kids as young as 5The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5
Read more »
FDA clears updated COVID boosters for kids as young as 5The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave. Tweaked boosters rolled out for Americans 12 and older last month, doses modified to target today’s most common and contagious omicron relative .
Read more »
FDA authorizes bivalent COVID-19 boosters for children ages 5 to 11Children ages 5 to 11 can now get a COVID booster after the FDA authorized the bivalent dose Wednesday from both Pfizer-BioNTech and Moderna.
Read more »
FDA clears updated COVID boosters for kids as young as 5The FDA has authorized updated COVID-19 boosters for children as young as 5, seeking to expand protection ahead of an expected winter wave.
Read more »